Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate.
It remains uncertain how calcium, phosphate and calcitriol regulate parathyroid cell growth. The present study was aimed at examining possible direct effects of these modulators and of the calcimimetic NPS R-467 on parathyroid cell growth in vitro. Cell proliferation was determined by [3H]thymidine incorporation and cell cycle antigen Ki 67 expression in a parathyroid cell culture model derived from uraemic patients. The effect of NPS R-467 on parathyroid hormone (PTH) secretion and intracellular [Ca2+]i response was also examined. Increasing the [Ca2+] in the medium from 0.5 to 1.7 mM increased DNA synthesis (P < 0.005) and the number of Ki 67-positive cells (P < 0.005). However, NPS R-467 (0.01-1 microM) inhibited 3[H]thymidine incorporation by 35% in the presence of 0.5 mM [Ca2+]e. Exposure of cells to Ca2+ or NPS R-467 led to a rapid increase of intracellular Ca2+, although the pattern of increase differed. Addition of calcitriol (10-10-10-7 M) to the culture medium suppressed [3H]thymidine incorporation dose-dependently. Finally, high levels of phosphate (3.5 mM) in the medium led to a significant (P < 0.05) increase in [3H]thymidine incorporation. The observed stimulatory effect of Ca2+ in the medium in vitro appears to be at variance with the inhibitory effect of calcimimetic NPS R-467 in vitro. In an attempt to solve these apparent discrepancies, and based on the notion of a reduced calcium-sensing receptor (CaR) expression in parathyroid tissues of uraemic patients, we hypothesize that Ca2+ may regulate parathyroid cell proliferation via two different pathways, with predominant growth inhibition in cases of high CaR expression or activation, but prevailing stimulation of proliferation in cases of low CaR expression.
Roussanne
M C
MC
Hôpital Necker, Paris, CNRS, Jouy en Josas, Hôpital Saint Louis, Paris, France. roussann@necker.fr
Lieberherr
M
M
Souberbielle
J C
JC
Sarfati
E
E
Drüeke
T
T
Bourdeau
A
A
D000814:Aniline Compounds / Q000494:pharmacology*; D002117:Calcitriol / Q000494:pharmacology*; D002118:Calcium / Q000819:agonists / Q000494:pharmacology*; D020013:Calcium Signaling; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006965:Hyperplasia; D007676:Kidney Failure, Chronic; D010279:Parathyroid Diseases; D010280:Parathyroid Glands / Q000166:cytology / Q000187:drug effects*; D010710:Phosphates / Q000494:pharmacology*
D000814:Aniline Compounds; C111654:NPS R-467; D010710:Phosphates; D002117:Calcitriol; D002118:Calcium